Japanese Marine and Shipping Stock News

Sompo Holdings (TSE:8630) is back in focus after the company reported progress on its open market share repurchase program, including completion of a ¥9.75b tranche. This has sharpened attention on its capital allocation plans. See our latest analysis for Sompo Holdings. The share buyback update comes after a strong run in Sompo Holdings' stock, with a 1 month share price return of 14.78% and a year to date share price return of 24.63%, alongside a 1 year total shareholder return of 65.55%...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Hankyu Hanshin Holdings (TSE:9042) has completed the repurchase of 4,868,700 shares, or 2.05% of outstanding stock, for ¥22,310.74 million, drawing fresh attention to its ongoing capital management approach. See our latest analysis for Hankyu Hanshin Holdings. Hankyu Hanshin Holdings’ recent buyback arrives after a mixed price pattern, with a 7.06% 7 day share price return and year to date share price return of 13.58%, while the 90 day share price return is down 5.31% and the 1 year total...

The subdued stock price reaction suggests that NEW ART HOLDINGS Co., Ltd.'s ( TSE:7638 ) strong earnings didn't offer...

Even though Naikai Zosen Corporation's ( TSE:7018 ) recent earnings release was robust, the market didn't seem to...

While TOKYO KEIKI INC. ( TSE:7721 ) might not have the largest market cap around , it received a lot of attention from...

Okayamaken Freight Transportation Co., Ltd. ( TSE:9063 ) announced strong profits, but the stock was stagnant. Our...

Watami Co., Ltd. ( TSE:7522 ) just reported healthy earnings but the stock price didn't move much. We think that...

Despite posting some strong earnings, the market for Hikari Tsushin, Inc.'s ( TSE:9435 ) stock hasn't moved much. Our...

What Takashimaya’s Latest Earnings Reveal Takashimaya Company (TSE:8233) reported first quarter sales of ¥96,187 million and net income of ¥11,082 million, compared with ¥90,824 million and ¥6,996 million a year earlier, putting its recent share performance into clearer context for investors. See our latest analysis for Takashimaya Company. Takashimaya’s latest results come after a strong run, with the share price up 36.31% year to date and the 1 year total shareholder return at 109.45%, even...

ARCS (TSE:9948) drew fresh attention after reporting first quarter results, with net sales up 2.7% year on year, operating profit up 5.9%, and profit attributable to owners rising 3.0%. See our latest analysis for ARCS. The first quarter update appears to have supported a stronger tone in ARCS shares recently, with a 1 month share price return of 9.15% and year to date gain of 4.45%. The 1 year total shareholder return of 18.71% and 5 year total shareholder return of 80.36% point to solid...

Nippon Shinyaku Co., Ltd. recently entered into an option agreement with Elixirgen Therapeutics to potentially secure exclusive worldwide rights to develop and commercialize EXG-7001, an investigational mRNA-based therapy for Duchenne muscular dystrophy that is currently in preclinical development ahead of planned U.S. trials. This move deepens Nippon Shinyaku’s rare-disease focus by targeting full-length dystrophin expression regardless of mutation type, potentially broadening the...

Daiichi Sankyo and AstraZeneca recently secured a European Commission approval for Enhertu across multiple HER2 positive metastatic solid tumors and received an EMA committee recommendation for Datroway as first-line treatment for certain triple-negative breast cancer patients, alongside board decisions on share-based compensation. These oncology milestones expand Daiichi Sankyo’s European treatment footprint, trigger a US$25 million milestone payment from AstraZeneca, and reinforce the...

Currency markets are back in the spotlight, with the Japanese yen hovering near 40 year lows, the U.S. dollar gaining ground, and central banks from the Federal Reserve to the Reserve Bank of New Zealand shaping interest rate expectations. That mix is creating sharp foreign exchange swings for Japanese companies that depend heavily on global revenue, and not every stock is positioned the same way. This article looks at three Japanese stocks that appear more exposed to the current yen...

In recent days, Morgan Stanley MUFG highlighted Yaskawa Electric’s outlook by pointing to expectations for strong first-quarter earnings and accelerating order growth. This focus on both earnings strength and order momentum underscores how closely investors are watching demand trends in factory automation and robotics. With these expectations around first-quarter earnings and order momentum in mind, we will now examine how this shapes Yaskawa Electric’s investment narrative. The best AI...

Sumitomo Mitsui Financial Group recently completed a share repurchase of 17,614,900 shares, or 0.46% of its stock, for ¥108,513.1 million, alongside multiple US dollar fixed-to-floating and floating rate bond issues totaling US$2.75 billion and governance updates including a stock split and dividend approval. Together with fresh Managing Director appointments across key regions and the election of a new director, these actions underscore SMFG’s focus on capital return, funding flexibility,...

Oracle Corporation Japan (TSE:4716) updated investors with new guidance for the year ending May 31, 2027, alongside an increase in its regular dividend and a sizeable special dividend that highlight current shareholder returns. See our latest analysis for Oracle Corporation Japan. At a share price of ¥8,826, Oracle Corporation Japan has recently gained ground with a 1-day share price return of 0.91% and a 7-day share price return of 3.65%. However, the share price return is still down 30.37%...

Daiwa House Industry recently reported quarterly earnings of ¥202.24 per share, well above the ¥116.97 per share analysts had expected. This earnings beat suggests the company’s underlying operations outperformed market assumptions, potentially reshaping how investors view its profit resilience and efficiency. We’ll now examine how Daiwa House Industry’s stronger-than-expected earnings performance could influence its broader investment narrative for shareholders. The future of work is here...

NS Solutions (TSE:2327) is back in focus after its June 19 shareholder meeting, where investors challenged how the company handles large cash deposits with its parent at low interest rates. See our latest analysis for NS Solutions. The recent focus on NS Solutions' deposits with its parent comes as the stock shows a 1 day share price return of 3.10% and 7 day share price return of 10.42%. The year to date share price return is down 17.93% and the 1 year total shareholder return is down 6.05%,...

Mitsui (TSE:8031) is drawing investor attention after increasing its India exposure, targeting semiconductors, e-mobility, and circular economy projects as Japanese investment into the country has reached about $25-35 billion post-COVID. See our latest analysis for Mitsui. At a share price of ¥4,600.0, Mitsui’s short term share price return has weakened, with a 30 day share price return down 8.71% and a 90 day share price return down 27.72%, even as the 1 year total shareholder return of...

Between April 1 and June 30, 2026, Advantest completed its October 2025 share buyback program, repurchasing a total of 3,614,800 shares (0.5% of shares outstanding) for ¥86,416.86 million, while also announcing a partnership with OpenLight to develop scalable, high-volume silicon photonics testing solutions. This collaboration with OpenLight is important because it targets end-to-end testing for next-generation silicon photonics used in data centers and high-speed networking, potentially...

On July 2, 2026, Insilico Medicine announced a collaboration with Takeda Pharmaceutical to apply its Pharma.AI platform to discover and optimize new drug candidates across Takeda’s therapeutic areas, in a deal that includes about US$60.00 million in initial and near-term payments and potential total value of about US$600.00 million plus tiered royalties, with Takeda gaining exclusive global rights to develop and commercialize any selected therapeutics. This AI-powered discovery partnership...

Terumo Interventional Systems recently completed the first U.S. procedure using its OPUSWAVE Dual Sensor Imaging System at Mount Sinai Fuster Heart Hospital, combining Optical Frequency Domain Imaging and intravascular ultrasound in a single catheter to enhance intravascular imaging for coronary interventions. This dual-modality platform directly targets physicians’ demand for clearer, real-time vessel visualization and procedural confidence, potentially strengthening Terumo’s position in...

ASKUL (TSE:2678) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥113.3b and a basic EPS loss of ¥90.78, capping a trailing twelve month picture that shows revenue of ¥400.2b and a full year EPS loss of ¥245.40. Over recent periods, the company has seen quarterly revenue move from ¥122.3b in Q4 FY 2025 to ¥113.3b in Q4 FY 2026, while quarterly basic EPS shifted from ¥31.42 to a loss of ¥90.78, underscoring a clear hit to profitability. For investors, these results put...